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INTRODUCTION
SUMMARY
Twenty eight ambulatory patients (16 men and 12 women), suffering from essential hyperten
sion, whose ages averaged 46.9 ± 9.6 years, were studied; the patients presented blood pressure
values of 174.0 ± 22.7 mmHg systolic and 110.5 ± 11.7 mmHg diastolic. It was detected a signifi
cant rise of erythrocyte membrane microviscosity (p < 0.01) and a significant decrease of eryth
rocyte filtrability (p < 0.001). However, no significant correlation was observed between these
two parameters. The results obtained suggest that essential hypertension induces or may be asso
ciated to intrinsic abnormalities of erythrocyte membrane eventually acting on globular flexibi
lity.
The maintenance of erythrocyte flexibility is vital
for globular survival in the bloodstream. The eryth
rocyte has the ability to deform owing to its fluidness
that may be affected by extrinsic and intrinsic factors.
The latter encompass the membrane properties.
Hypertensive disease courses with high viscosity,1’2’3
decreased erythrocyte flexibility4 and biochemical and
functional abnormalities of erythrocyte membranes.5’6’7
The aim of this work is to correlate. the index of
erythrocyte filtrability with globular membrane mi
croviscosity in patients suffering from essential hyper
tension.
METHODS
A total of 28 patients with essential hypertension
were examined. The group, consisting of 16 male and
12 females, with 46.0 ± 9.6 (mean ± SD) years of
age presented moderate levels of hypertension
(174.0 ± 22.7 mmHg for systolic and 110.5 ± 11.7
mmHg for diastolic) and reduced systemic repercus
sions.
The haemoglobin free ghosts were prepared at
4°C by the method o Cha et al.8
Protein concentration was determined according
to the method of Lowry et al (9). Ghost pellets were
suspended on 1.2 ml of sodium phosphate buffer 155
mM and treated like the procedure of Schiliro G. et
aV° for fluorescence polarization measurements, per
formed at 25°C ± 1 with a Perkin Elmer, MPF-3
fluorescence spectrophotometer. The values of the
fluorescence polarization (p) were calculated by the
formula:
— ‘HH — OHv . ~ / Ivy
‘HH ~ (‘Hv IvH) / Ivy
where ‘HH and ‘vv are the fluorescence intensities
measured with the polarizer and the analyzer placed
with both their planes of polarization, horizontal and
vertical, respectively. 1i-iv is the fluorescence intensity
observed with the polarizer placed with its plane pola
rization horizontal and the analyzer vertical. ~ is the
fluorescence intensity measured with polarizer and
analyzer both rotated by 90° with respect to the pre
vious setting. To this values of fluorescence intensities
must be subtracting the scattering components. The
microviscosity equivalent ~ (poise) can be derived ac
cording to following relation~hip:”
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The red cell filtrability rate, hematocrit corrected,
was determined according to the method of Reid et
al. 12
RESULTS AND DISCUSSION
The compound l,6-diphenyl-1, 3, 5-hexatrien
(DPH) is a fluorescent probe used for the study of
dynamic properties of the aliphatic region of mem
brane forming hydrocarbons.’3
The microviscosity of erythrocyte membrane, as
assessed with DPH, presents a significantly higher
(p < 0.01) values among the hypertensive patients
(4.07 ± 1.49; mean ± SD) than among the controls
(2.89 ± 0.76); contrariwise, the index of erythrocyte
filtration is significantly lower (p < 0.001) in the
hypertensive patients (12.84 ± 2.98 j.il. seg’) than in
the control group (15.80 ± 1.75 gil. segi. However,
no significant correlation was established between
these two parameters.
In a previous report, Montaney-Garestiert et al’4
observed that fluorescence polarization of DPH in
erythrocyte membrane of hypertensive rats was higher
than the value found for membrane of rats with nor
mal blood pressure.
The levels of erythrocyte filtration rate of hyper
tensive patients observed in this work are comparable
to those previously reported.3’4
The results obtained in this work add evidence to
the abnormalities reported in the erythrocytes and
globular membranes of hypertensioe patients. Howe
ver, since the effects of membrane microviscosity
seem not to interfere significantly in erythrocyte fil
trability (as suggested by the absence of correlation),
it must be assumed that the values of this parameter
do not only indicate a decrease of flexibility but also
express extraglobular abnormalities that influence
blood rheology. Besides, erythrocyte membrane mi
croviscosity is not equivalent to membrane viscosity
(which is a resistance to the motion of the membrane).
The measurement of this variable could be more rela
ted to red cell deformability.
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